Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

Sabrina Martyr, MD, Arun Balakumuran, MD, PhD, Aldemar Montero, MD, Cynthia E. Dunbar, MD, Elizabeth M. Kang, MD, Phillip Scheinberg, MD, Barbara Weinstein, RN, Xin Tian, Ph.D., Neal S. Young, MD, Adrian Wiestner, MD, PhD

Blood (2013) 122 (21): 2479.

https://doi.org/10.1182/blood.V122.21.2479.2479

Published: 2013

Journal Articles

High donor FOXP3 -positive regulatory T-cell (T reg ) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

Katayoun Rezvani, Stephan Mielke, Mojgan Ahmadzadeh, Yasemin Kilical, Bipin N. Savani, Josette Zeilah, Keyvan Keyvanfar, Aldemar Montero, Nancy Hensel, Roger Kurlander, A. John Barrett

Blood (2006) 108 (4): 1291–1297.

https://doi.org/10.1182/blood-2006-02-003996

Published: 2006

Journal Articles

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia

Bipin N. Savani, Katayoun Rezvani, Stephan Mielke, Aldemar Montero, Roger Kurlander, Charles S. Carter, Susan Leitman, Elizabeth J. Read, Richard Childs, A. John Barrett

Blood (2006) 107 (4): 1688–1695.

https://doi.org/10.1182/blood-2005-05-1897

Published: 2006

Journal Articles

T-Cell Depleted PBSCT Mitigates Acute GVHD, but Preserves Protective Chronic GVHD. Long Term Follow up of 138 Patients.

Aldemar Montero, MD, Bipin N. Savani, MD, Stephan Mielke, MD, Scott R. Solomon, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 140.

https://doi.org/10.1182/blood.V106.11.140.140

Published: 2005

Journal Articles

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Bipin N. Savani, MD, Ramaprasad Srinivasan, MD, PhD, Aldemar Montero, MD, Anurag Singh, MD, Aarthi Shenoy, MD, Shervin Kamipour, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1116.

https://doi.org/10.1182/blood.V106.11.1116.1116

Published: 2005

Journal Articles

Transplant Outcome in Acute Myeloid but Not Acute Lymphocytic Leukemia Following T Cell Depleted Allogeneic Stem Cell Transplantation May Be Favorably Influenced by Early Recovery of NK Cells.

Bipin N. Savani, MD, Aldemar Montero, MD, Stephan Mielke, MD, Katayoun Rezvani, MD, Aarthi Shenoy, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1405.

https://doi.org/10.1182/blood.V106.11.1405.1405

Published: 2005

Journal Articles

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

Scott R. Solomon, Stephan Mielke, Bipin N. Savani, Aldemar Montero, Laura Wisch, Richard Childs, Nancy Hensel, John Schindler, Victor Ghetie, Susan F. Leitman, Thao Mai, Charles S. Carter, Roger Kurlander, Elizabeth J. Read, Ellen S. Vitetta, A. John Barrett

Blood (2005) 106 (3): 1123–1129.

https://doi.org/10.1182/blood-2005-01-0393

Published: 2005

Journal Articles

Prediction and Prevention of Transplant Related Mortality from Pulmonary Causes Following Total Body Irradiation and Allogeneic Stem Cell Transplantation.

Bipin Savani, M.D, Aldemar Montero, M.D., Bernadette Gochiuo, Nene Nlonda, Richard Childs, M.D, Scott Solomon, M.D., John Barrett, M.D.

Blood (2004) 104 (11): 1836.

https://doi.org/10.1182/blood.V104.11.1836.1836

Published: 2004

Journal Articles

Favorable Impact of T Cell Depleted PBSCT on Transplant Outcomes Despite Delayed Donor T Cell Engraftment.

Aldemar Montero, MD, Roger Kurlander, MD, Elizabeth Read, MD, Susan Leitman, MD, Nene Nlonda, Neal Young, MD, Richard Childs, MD, Scott Solomon, MD, John Barrett, MD

Blood (2004) 104 (11): 182.

https://doi.org/10.1182/blood.V104.11.182.182

Published: 2004

Journal Articles

Improved Outcomes for Peripheral Blood Stem Cell Transplantation in Advanced Myelodysplastic Syndrome.

Scott R. Solomon, M.D., Richard Childs, M.D., Aldemar Montero, M.D, Elaine Sloand, M.D., Laura Wisch, R.N., Leslie Wehrlen, R.N., John Barrett, M.D.

Blood (2004) 104 (11): 2304.

https://doi.org/10.1182/blood.V104.11.2304.2304

Published: 2004

NARROW

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

High donor FOXP3 -positive regulatory T-cell (T reg ) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia

T-Cell Depleted PBSCT Mitigates Acute GVHD, but Preserves Protective Chronic GVHD. Long Term Follow up of 138 Patients.

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Transplant Outcome in Acute Myeloid but Not Acute Lymphocytic Leukemia Following T Cell Depleted Allogeneic Stem Cell Transplantation May Be Favorably Influenced by Early Recovery of NK Cells.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

Prediction and Prevention of Transplant Related Mortality from Pulmonary Causes Following Total Body Irradiation and Allogeneic Stem Cell Transplantation.

Favorable Impact of T Cell Depleted PBSCT on Transplant Outcomes Despite Delayed Donor T Cell Engraftment.

Improved Outcomes for Peripheral Blood Stem Cell Transplantation in Advanced Myelodysplastic Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only